156 related articles for article (PubMed ID: 16027043)
1. Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.
Desplat-Jégo S; Creidy R; Varriale S; Allaire N; Luo Y; Bernard D; Hahm K; Burkly L; Boucraut J
Clin Immunol; 2005 Oct; 117(1):15-23. PubMed ID: 16027043
[TBL] [Abstract][Full Text] [Related]
2. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.
Santambrogio L; Hochwald GM; Saxena B; Leu CH; Martz JE; Carlino JA; Ruddle NH; Palladino MA; Gold LI; Thorbecke GJ
J Immunol; 1993 Jul; 151(2):1116-27. PubMed ID: 8335893
[TBL] [Abstract][Full Text] [Related]
6. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
[TBL] [Abstract][Full Text] [Related]
7. Triptolide modulates T-cell inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Wang Y; Mei Y; Feng D; Xu L
J Neurosci Res; 2008 Aug; 86(11):2441-9. PubMed ID: 18438925
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
[TBL] [Abstract][Full Text] [Related]
9. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.
Piccio L; Buonsanti C; Mariani M; Cella M; Gilfillan S; Cross AH; Colonna M; Panina-Bordignon P
Eur J Immunol; 2007 May; 37(5):1290-301. PubMed ID: 17407101
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease.
Toft-Hansen H; Füchtbauer L; Owens T
Glia; 2011 Jan; 59(1):166-76. PubMed ID: 21046558
[TBL] [Abstract][Full Text] [Related]
11. IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity.
Nizri E; Irony-Tur-Sinai M; Lavon I; Meshulam H; Amitai G; Brenner T
Int Immunopharmacol; 2007 Sep; 7(9):1129-39. PubMed ID: 17630191
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against T-cell receptor alphabeta induces self-tolerance in chronic experimental autoimmune encephalomyelitis.
Lavasani S; Dzhambazov B; Andersson M
Scand J Immunol; 2007 Jan; 65(1):39-47. PubMed ID: 17212765
[TBL] [Abstract][Full Text] [Related]
14. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis.
Nicholas AP; Sambandam T; Echols JD; Barnum SR
J Comp Neurol; 2005 Jun; 486(3):254-66. PubMed ID: 15844173
[TBL] [Abstract][Full Text] [Related]
15. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
Villares R; Cadenas V; Lozano M; Almonacid L; Zaballos A; Martínez-A C; Varona R
Eur J Immunol; 2009 Jun; 39(6):1671-81. PubMed ID: 19499521
[TBL] [Abstract][Full Text] [Related]
16. TWEAK stimulation of astrocytes and the proinflammatory consequences.
Saas P; Boucraut J; Walker PR; Quiquerez AL; Billot M; Desplat-Jego S; Chicheportiche Y; Dietrich PY
Glia; 2000 Oct; 32(1):102-7. PubMed ID: 10975915
[TBL] [Abstract][Full Text] [Related]
17. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
18. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
19. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
Genoud S; Maricic I; Kumar V; Gage FH
J Neuroimmunol; 2005 Nov; 168(1-2):40-5. PubMed ID: 16120466
[TBL] [Abstract][Full Text] [Related]
20. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
